AR126219A1 - TRANSFORMING GROWTH FACTOR b LIGAND TRAPS FOR THE TREATMENT OF DISEASES - Google Patents
TRANSFORMING GROWTH FACTOR b LIGAND TRAPS FOR THE TREATMENT OF DISEASESInfo
- Publication number
- AR126219A1 AR126219A1 ARP220101657A ARP220101657A AR126219A1 AR 126219 A1 AR126219 A1 AR 126219A1 AR P220101657 A ARP220101657 A AR P220101657A AR P220101657 A ARP220101657 A AR P220101657A AR 126219 A1 AR126219 A1 AR 126219A1
- Authority
- AR
- Argentina
- Prior art keywords
- growth factor
- ligand traps
- transforming growth
- tgf
- diseases
- Prior art date
Links
Abstract
La presente solicitud se refiere a métodos que utilizan trampas de ligandos del factor de crecimiento transformador b (TGF-b). Las trampas de ligandos del TGF-b descritas en el presente documento pueden ser adecuadas para una terapia de combinación con una inmunoterapia, para tratar una enfermedad o trastorno tal como un cáncer. Las trampas de ligandos del TGF-b descritas en el presente documento también pueden ser adecuadas para monoterapia para tratar una enfermedad o trastorno tal como un cáncer. En particular, en el presente documento se proporcionan métodos y composiciones para tratar una enfermedad o trastorno, tal como un cáncer, mediante la administración de una trampa de ligandos del TGF-b en combinación con un inhibidor de puntos de control inmunitario.The present application relates to methods using transforming growth factor b (TGF-b) ligand traps. The TGF-b ligand traps described herein may be suitable for combination therapy with an immunotherapy, to treat a disease or disorder such as cancer. The TGF-b ligand traps described herein may also be suitable for monotherapy to treat a disease or disorder such as cancer. In particular, provided herein are methods and compositions for treating a disease or disorder, such as cancer, by administering a TGF-b ligand trap in combination with an immune checkpoint inhibitor.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063214588P | 2020-06-24 | 2020-06-24 | |
US202163214585P | 2021-06-24 | 2021-06-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR126219A1 true AR126219A1 (en) | 2023-09-27 |
Family
ID=88197391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP220101657A AR126219A1 (en) | 2020-06-24 | 2022-06-23 | TRANSFORMING GROWTH FACTOR b LIGAND TRAPS FOR THE TREATMENT OF DISEASES |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR126219A1 (en) |
-
2022
- 2022-06-23 AR ARP220101657A patent/AR126219A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020009773A (en) | Combination therapy. | |
CR20170477A (en) | FIBROBLAST GROWTH FACTOR RECEIVER COMBINATION THERAPY (FGFR) / SCHEDULED DEATH 1 (PD 1) FOR THE TREATMENT OF THE CNCER | |
EA202091846A1 (en) | COMPOUNDS WITH FERROPTOSIS-INDUCING ACTIVITY AND METHODS OF THEIR APPLICATION | |
MX2023007212A (en) | Epinephrine spray formulations. | |
AR101740A1 (en) | COMBINATION AND COMPOSITION THERAPY | |
EA201892190A1 (en) | TREATMENT OF PSORIASIS WITH ANTI-BODY TO IL-12 AND / OR IL-23 WITH THE GROWTH OF THE INTERVAL BETWEEN THE INTRODUCTION OF DOSE | |
MX2020001727A (en) | Combination therapy. | |
CO2023017973A2 (en) | Transforming Growth Factor βeta Ligand Traps for Disease Treatment | |
EA202192122A1 (en) | COMPOUNDS WITH FERROPTOSE-INDUCING ACTIVITY AND METHODS FOR THEIR APPLICATION | |
AR119507A1 (en) | TRISPECIFIC ANTI-PD-1/LAG3/TIGIT ANTIBODIES AND BISPECIFIC ANTI-PD-1/LAG3 ANTIBODIES | |
EA202193111A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | |
CL2019001749A1 (en) | Use of anti-sclerostin antibodies in the treatment of imperfect osteogenesis. | |
MX2019013862A (en) | Combination therapy. | |
BR112022024483A2 (en) | METHODS TO TREAT MULTIPLE MYELOMA | |
MX2022003194A (en) | Treatment of behavioral impairment in developmental and epileptic encephalopathy. | |
CO2022002573A2 (en) | Antibodies against ilt2 and their use | |
EA201891007A1 (en) | AIMING FOR FORMILPEPTID RECEPTOR 2 / LIPOXIN A RECEPTOR (FPR2 / ALX) FOR TREATING HEART DISEASES | |
AR122352A1 (en) | A C21-N-PYRAZOLIL 19-NOR C3,3 DISUBSTITUTED STEROID AND METHODS OF USE OF IT | |
CL2021002966A1 (en) | Combination of pd-1 inhibitors and lag-3 inhibitors to improve efficacy in cancer treatment. | |
BR112022003659A2 (en) | Compositions and methods of treatment of vascular diseases | |
CO2019003865A2 (en) | Therapeutic protein | |
BR112016023011A2 (en) | gastric cancer treatment | |
EA201990613A1 (en) | ANTIBODIES AGAINST GREEMLIN-1 (GREM1) AND METHODS OF THEIR APPLICATION FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION | |
MX2020008881A (en) | Methods of treatment of cancer comprising chk1 inhibitors. | |
EA202091112A1 (en) | SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION |